GENEVA, SWITZERLAND – OCTOBER 2, 2023
Two new members, Dr Zoë Johnson and Reinhard K. Stary, have joined Adiposs’ board of directors.
Adiposs SA is thrilled to welcome two new board members, Dr Zoë Johnson and Mr Reinhard Stary. They both have more than 25 years of international experience working in small, medium and large size companies.
Zoë brings scientific and clinical expertise in immunology and immuno-oncology. She is an expert in the development of immunotherapeutic assets and has successfully brought several new chemical and biological entities into clinical development.
Reinhard, appointed as the new Chairman of the board, is a seasoned C-level and board level executive, with over 25 years of experience working for small, medium and large sized companies in executive and non-executive board roles, currently also serving as the chairman at three other technology startups and scaleups in Europe
“We are delighted to have Zoë and Reinhard joining the board of directors”, says Dr Andrej Babic, CEO and co-founder. “They are bringing a wealth of biotech, medtech, financing and board leadership experience with excellent track records. We look forward to their support and guidance on the company’s strategy to achieve our mission and vision.”
“I am delighted to be joining Adiposs at an exciting stage of the company’s evolution”, said Dr Zoë Johnson. “I look forward to working with the team to bring ImageBAT™ into routine clinical use with the aim to improve patient stratification for response to immunotherapy.”
On his appointment as chairman, Reinhard said, “I am impressed by the stage of development of Adiposs under the leadership of Andrej and I very much look forward to working with the board on further developing and guiding the company and to supporting Andrej and his team to achieve Adiposs’ mission of saving lives with their new game-changing technology, ImageBAT™.”